Cleaved-Caspase-7 p20 (D198) Polyclonal Antibody

CASP7 encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. The precursor of the encoded caspase 7 is cleaved by caspase 3 and 10, is activated upon cell death stimuli and induces apoptosis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for CASP7.

Introducing the Cleaved-Aggrecan (D369) Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate accurate and reliable detection of cleaved aggrecan protein in various biological samples. This high-quality antibody has been meticulously developed using advanced techniques to ensure exceptional specificity and sensitivity, enabling researchers to delve deeper into the intricate mechanisms underlying aggrecan cleavage.

The Cleaved-Aggrecan (D369) Polyclonal Antibody boasts an impressive range of applications, making it an invaluable asset in diverse research fields such as molecular biology, biochemistry, and cell biology. Its versatility allows for the precise identification and quantification of cleaved aggrecan in tissues, cell lysates, and other biological matrices, enabling comprehensive investigations into the role of aggrecan cleavage in physiological and pathological processes.

Crafted with utmost precision, this polyclonal antibody exhibits exceptional affinity towards cleaved aggrecan, ensuring minimal cross-reactivity with non-specific proteins. Its superior sensitivity empowers researchers to detect even trace amounts of cleaved aggrecan, facilitating accurate and reliable quantification. Furthermore, the antibody's robust performance guarantees consistent and reproducible results, enabling researchers to confidently draw meaningful conclusions from their experiments.

The Cleaved-Aggrecan (D369) Polyclonal Antibody is accompanied by comprehensive technical support, including detailed protocols and expert guidance, ensuring seamless integration into experimental workflows. Its user-friendly nature allows for straightforward implementation, saving valuable time and resources.

In summary, the Cleaved-Aggrecan (D369) Polyclonal Antibody represents a breakthrough in the field of aggrecan cleavage research. With its exceptional specificity, sensitivity, and versatility, this antibody empowers scientists to unravel the intricate mechanisms underlying aggrecan cleavage, paving the way for groundbreaking discoveries in various scientific disciplines.